Top Story

PARTNER II Valve-in-Valve registry suggests alternative to reoperation in failed aortic bioprostheses

November 30, 2015

Valve-in-valve transcatheter valve replacement using Sapien XT appears to be a valuable alternative to reoperation in patients with failed aortic bioprostheses, according to 1-year results from the PARTNER II registry presented at the annual TCT Scientific Symposium.

Danny Dvir, MD, and colleagues evaluated 197 patients (mean age, 78.5 ± 11 years, 60.4% male) with symptomatic severe stenosis or regurgitation of a surgical aortic tissue valve at high risk for reoperation, defined as estimated surgical mortality or major morbidity of ≥ 50%.

FDA News

FDA approves rosuvastatin for use in youth aged 8 to 17 with HeFH

November 30, 2015
AstraZeneca announced that the FDA has approved rosuvastatin to reduce total cholesterol, LDL and apolipoprotein B in pediatric patients aged 8 to 17 years with…
SupplementPublication Exclusive

Research highlights progress of PROMISE, controversies in treatment of chronic angina

Cardiology Today, November 2015
New-onset stable chest pain or angina in those without diagnosed heart disease affects about 4 million Americans per year. In response, the editors of Cardiology
In the Journals

Novel oral anticoagulants may reduce stroke, bleeding risk in patients with renal impairment

November 30, 2015
In patients with mild or moderate renal impairment, the use of novel oral anticoagulants appears to confer reduced risks for stroke or systemic embolism, as well as for…
In the Journals

Stroke, CHD more likely in black adults with depressive symptoms

November 30, 2015
New data from the Jackson Heart Study indicate that blacks with symptoms of major depression are at increased risk for incident stroke and may be at increased risk for…
More News Headlines »

The Patient with Coronary Artery Disease and an Acute Ischemic Stroke

No commercial support for this activity.

Patients with hypertension, coronary artery disease, systemic atherosclerosis and heart failure are at increased risk…
More »
Meeting News Coverage Video

VIDEO: Liraglutide fails to improve HF outcomes in FIGHT trial

November 28, 2015
More »

Mechanism of Action of Currently Approved Antiplatelet Agents

This activity is supported by an educational grant from Merck & Co., Inc.

In this CME activity, leading experts discuss the mechanism of action of antiplatelet agents in high-risk patients for…
More »
morganatic-roan morganatic-roan